|
450. |
Buttgereit, T.*, Vera, C.*, Weller, K., Gutsche, A., Grekowitz, E. M., Aykanat, S., Wahl, V., Krüger, R., Maurer, M.+, and Magerl, M.: Lanadelumab efficacy, safety, and injection interval extension in HAE – a real life study. J. Allergy Clin. Immunol. Pract. 2021: 9; 3744-3751. IF: 11.02 |
o.450
| 53. | Gower, R. G., Busse, P. J., Aygören-Pürsün, E., Barakat, A. J., Caballero, T., Davis-Lorton, M., Farkas, H., Hurewitz, D. S., Jacobs, J. S., Johnston, D. T., Lumry, W., and Maurer, M.: Hereditary angioedema caused by C1-Esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies. World Allergy Organ. J. 2011: 4; S9-S21. IF: N/A |
| 328 | Zanichelli, A.*, Magerl, M., Longhurst, H. J., Aberer, W., Caballero, T., Bouillet, L., Bygum, A., Grumach, A. S., Botha, J., Andresen, I., and Maurer, M.: Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the icatibant outcome survey. Clin. Transl. Allergy 2018: 8; 42 eCollection. IF: 4.23 |
| 141 | Craig, T., Aygören Pürsün, E., Bork, K., Bowen, T., Boysen, H., Farkas, H., Grumach, A. S., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W. R., Magerl, M., Martinez-Saguer, I., Ritchie, B., Nast, A., Zuraw, B. L., and Maurer, M.+: WAO Guideline for the management of hereditary angioedema: World Allergy Organization consensus document. World Allergy Organ. J. 2012: 5; 182-199. IF: N/A |
o.141